CDC vaccine advisers delay controversial vote on hepatitis B vaccine
PositiveU.S News

In a surprising turn of events, key vaccine advisers to the CDC voted 11-1 to delay a recommendation regarding changes to the hepatitis B vaccine for newborns. This decision has been met with relief by infectious disease experts who were concerned about the implications of the proposed changes. The delay allows for further discussion and consideration of the vaccine's necessity, ensuring that the health and safety of newborns remain a priority.
— Curated by the World Pulse Now AI Editorial System